5 Biggest Biotechnology ETFs in 2026
Source: Investing News Network
2026-06-02 16:10:00 ET
The biotech sector has made significant strides in recent years, and the market's volatility can increase the appeal of biotech ETFs.
Even with a good understanding of the system, no one can predict which treatment, device or therapy will give the biggest return, making biotech exchange-traded funds (ETFs) a more secure option than individual biotech stocks.
An ETF is a relatively safe investment route that can minimize losses while offering exposure to multiple companies instead of focusing on the gains and losses of a single biotech stock.
For further details see:
5 Biggest Biotechnology ETFs in 2026
Corcept Therapeutics Incorporated
NASDAQ: CORT
CORT Trading
3.69% G/L:
$74.775 Last:
321,855 Volume:
$72.79 Open:
CORT Latest News
May 29, 2026 04:33:00 pm
Corcept Presents New Data at ASCO 2026: Lifyorli(TM) Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure
CORT Stock Data
$4,351,636,537
83,309,068
0.22%
163
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
